Related references
Note: Only part of the references are listed.Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use
George Mihai Nitulescu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Genetic progression of malignant melanoma
J. Timar et al.
CANCER AND METASTASIS REVIEWS (2016)
Computational modeling of the expansion of human cord blood CD133(+) hematopoietic stem/progenitor cells with different cytokine combinations
Francesca Gullo et al.
BIOINFORMATICS (2015)
Insight into molecular dynamics simulation of BRAF(V600E) and potent novel inhibitors for malignant melanoma
Hsin-Chieh Tang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2015)
Agent based modeling of the effects of potential treatments over the blood-brain barrier in multiple sclerosis
Marzio Pennisi et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2015)
Computational modelling approaches to vaccinology
Francesco Pappalardo et al.
PHARMACOLOGICAL RESEARCH (2015)
Systems biology approaches for advancing the discovery of effective drug combinations
Karen A. Ryall et al.
JOURNAL OF CHEMINFORMATICS (2015)
Melanoma
Dirk Schadendorf et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Induction of T-cell memory by a dendritic cell vaccine: a computational model
Francesco Pappalardo et al.
BIOINFORMATICS (2014)
Big data in biomedicine
Fabricio F. Costa
DRUG DISCOVERY TODAY (2014)
Mathematical modeling for novel cancer drug discovery and development
Ping Zhang et al.
EXPERT OPINION ON DRUG DISCOVERY (2014)
Analyzing methods for path mining with applications in metabolomics
Somnath Tagore et al.
GENE (2014)
Emerging targeted therapies for melanoma treatment (Review)
Angela Russo et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Constraint-based models predict metabolic and associated cellular functions
Aarash Bordbar et al.
NATURE REVIEWS GENETICS (2014)
Analysis of the B-RAFV600E mutation in cutaneous melanoma patients with occupational sun exposure
Saverio Candido et al.
ONCOLOGY REPORTS (2014)
Data-Derived Modeling Characterizes Plasticity of MAPK Signaling in Melanoma
Marti Bernardo-Faura et al.
PLOS COMPUTATIONAL BIOLOGY (2014)
Modeling Biology Spanning Different Scales: An Open Challenge
Filippo Castiglione et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Mathematical modeling of biological systems
Santo Motta et al.
BRIEFINGS IN BIOINFORMATICS (2013)
PI3K and MEK inhibitor combinations: examining the evidence in selected tumor types
Carolyn D. Britten
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Formalizing an Integrative, Multidisciplinary Cancer Therapy Discovery Workflow
Mary F. McGuire et al.
CANCER RESEARCH (2013)
The Combination of Exposure-Response and Case-Control Analyses in Regulatory Decision Making
Jun Yang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Modeling cancer immunotherapy: Assessing the effects of lymphocytes on cancer cell growth and motility
R. A. Ramos et al.
PHYSICA A-STATISTICAL MECHANICS AND ITS APPLICATIONS (2013)
Multi-scale agent-based modeling on melanoma and its related angiogenesis analysis
Jun Wang et al.
THEORETICAL BIOLOGY AND MEDICAL MODELLING (2013)
Novel Computational Approaches to Polypharmacology as a Means to Define Responses to Individual Drugs
Lei Xie et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52 (2012)
Cross-talk between mitogenic Ras/MAPK and survival PI3K/Akt pathways: a fine balance
Edita Aksamitiene et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
Clinical development of phosphatidylinositol 3-kinase inhibitors for cancer treatment
Irene Brana et al.
BMC MEDICINE (2012)
A Mathematical Model of Immune-System-Melanoma Competition
Marzio Pennisi
COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE (2012)
Gene alterations in the PI3K/PTEN/AKT pathway as a mechanism of drug-resistance (Review)
Sameh Hafsi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Virtual Screening Data Fusion Using Both Structure- and Ligand-Based Methods
Fredrik Svensson et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2012)
Combining cellular automata and lattice Boltzmann method to model multiscale avascular tumor growth coupled with nutrient diffusion and immune competition
Davide Alemani et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2012)
Chronic renoprotective effect of pulsatile perfusion machine RM3 and IGL-1 solution in a preclinical kidney transplantation model
Raphael Thuillier et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Sensitivity to the MEK inhibitor E6201 in melanoma cells is associated with mutant BRAF and wildtype PTEN status
Sara A. Byron et al.
MOLECULAR CANCER (2012)
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
Axel Hauschild et al.
LANCET (2012)
Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Multi-Parametric Analysis and Modeling of Relationships between Mitochondrial Morphology and Apoptosis
Yara Reis et al.
PLOS ONE (2012)
Routine Multiplex Mutational Profiling of Melanomas Enables Enrollment in Genotype-Driven Therapeutic Trials
Christine M. Lovly et al.
PLOS ONE (2012)
Mathematical and Computational Models in Tumor Immunology
F. Pappalardo et al.
MATHEMATICAL MODELLING OF NATURAL PHENOMENA (2012)
Multiscale Cancer Modeling
Thomas S. Deisboeck et al.
ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 13 (2011)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
SimB16: Modeling Induced Immune System Response against B16-Melanoma
Francesco Pappalardo et al.
PLOS ONE (2011)
Fast integration of heterogeneous data sources for predicting gene function with limited annotation
Sara Mostafavi et al.
BIOINFORMATICS (2010)
Mass Action Stoichiometric Simulation Models: Incorporating Kinetics and Regulation into Stoichiometric Models
Neema Jamshidi et al.
BIOPHYSICAL JOURNAL (2010)
Modeling the competition between lung metastases and the immune system using agents
Marzio Pennisi et al.
BMC BIOINFORMATICS (2010)
In silico Modeling and In vivo Efficacy of Cancer-Preventive Vaccinations
Arianna Palladini et al.
CANCER RESEARCH (2010)
Advances in computational methods to predict the biological activity of compounds
Chanin Nantasenamat et al.
EXPERT OPINION ON DRUG DISCOVERY (2010)
In silico designing and optimization of anti-breast cancer antibody mimetic oligopeptide targeting HER-2 in women
Bashir A. Akhoon et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2010)
Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference
Britta Wahren et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Fuzzy modeling of signal transduction networks
Zuyi Huang et al.
CHEMICAL ENGINEERING SCIENCE (2009)
Targeting the phosphoinositide 3-kinase pathway in cancer
Pixu Liu et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes
Yanfang Guo et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2008)
Efficacy of Weekly Docetaxel and Bevacizumab in Mesenchymal Chondrosarcoma: A New Theranostic Method Combining Xenografted Biopsies with a Mathematical Model
Boris Gorelik et al.
CANCER RESEARCH (2008)
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
Scott M. Wilhelm et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Big data: The future of biocuration
Doug Howe et al.
NATURE (2008)
Network pharmacology: the next paradigm in drug discovery
Andrew L. Hopkins
NATURE CHEMICAL BIOLOGY (2008)
A Matlab library for solving quasi-static volume conduction problems using the boundary element method
M. Stenroos et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2007)
Safety and immunogenicity of tyrosinase DNA vaccines in patients with melanoma
Jedd D. Wolchok et al.
MOLECULAR THERAPY (2007)
Computational model predicts effective delivery of 188-Re-labeled melanin-binding antibody to metastatic melanoma tumors with wide ranne of melanin concentrations
Andrew D. Schweitzer et al.
MELANOMA RESEARCH (2007)
Network-based classification of breast cancer metastasis
Han-Yu Chuang et al.
MOLECULAR SYSTEMS BIOLOGY (2007)
Neuroarchitecture of Peptidergic Systems in the Larval Ventral Ganglion of Drosophila melanogaster
Jonathan G. Santos et al.
PLOS ONE (2007)
Systems biology by the rules: hybrid intelligent systems for pathway modeling and discovery
William J. Bosl
BMC SYSTEMS BIOLOGY (2007)
PharmGKB: a logical home for knowledge relating genotype to drug response phenotype
Russ B. Altman
NATURE GENETICS (2007)
Mechanisms of disease - Melanoma
Arlo J. Miller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Mathematical modeling of intracellular signaling pathways
Edda Klipp et al.
BMC NEUROSCIENCE (2006)
Applying computational modeling to drug discovery and development
Neil Kumar et al.
DRUG DISCOVERY TODAY (2006)
Analysis of BRAF mutation in primary and metastatic melanoma
M Libra et al.
CELL CYCLE (2005)
Prediction and validation of the distinct dynamics of transient and sustained ERK activation
S Sasagawa et al.
NATURE CELL BIOLOGY (2005)
Role of pharmacoproteomics in the development of personalized medicine
KK Jain
PHARMACOGENOMICS (2004)
Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma
H Tsao et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
Phosphatidylinositol 3-kinase activates ERK in primary sensory neurons and mediates inflammatory heat hyperalgesia through TRPV1 sensitization
ZY Zhuang et al.
JOURNAL OF NEUROSCIENCE (2004)
The statistical mechanics of complex signaling networks: nerve growth factor signaling
KS Brown et al.
PHYSICAL BIOLOGY (2004)
Moving towards individualized medicine with pharmacogenomics
WE Evans et al.
NATURE (2004)
Phosphatidylinositol 3-kinase is a central mediator of NMDA receptor signalling to MAP kinase (Erk1/2), Akt/PKB and CREB in striatal neurones
MS Perkinton et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Role of phosphoinositide 3-kinase and endocytosis in nerve growth factor-induced extracellular signal-regulated kinase activation via Ras and Rap1
RD York et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
